Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole vs Itraconazole in Pityriasis Versicolor
NCT05862714Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in pityriasis versicolor comparing Group A Fluconazole with Group B Itraconazole (2 arms). Primary endpoints: Clinical Improvement Resolution of symptoms at 4 weeks and Efficacy of treatment through KOH mount at 4 weeks. Started Mar 2022; status: completed.
02
Drugs
fluconazoleitraconazole
03
Conditions
pityriasis versicolor
Beyond the preview
Go deeper on NCT05862714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05862714.